{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:57:24Z","timestamp":1788206244936,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As one of the most common causes of stroke, symptomatic intracranial artery stenosis (sICAS) is a great threat to public health, and its financial burden is substantial, with annual direct high medical costs particularly in China. Currently, the long-term use of conventional dual antiplatelet therapy (DAPT) as the primary modality of treatment for sICAS decreases the risk of stroke recurrence but increases the risk of bleeding. We aimed to evaluate the efficacy and safety of low dose aspirin plus clopidogrel for the treatment of sICAS in the elderly population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This randomized, controlled study included 181 older patients with transient ischemic attack (TIA) or ischemic stroke (IS) attributed to sICAS, who were recruited between April 2015 and November 2020. The 90 patients assigned to the low dose therapy group included aspirin, 75 mg, plus clopidogrel, 50 mg, daily for 90 and 91 patients assigned to the conventional group included aspirin, 100 mg, plus clopidogrel, 75 mg, daily for 90 days (aspirin or clopidogrel alone daily thereafter) were included in this intention-to-treat analysis. Efficacy and safety analyses were done in this trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred eighty-one eligible elderly patients with sICAS were enrolled in this trial. The median age was 70 years ranged 60\u201383 years. Seventy-five participants were with TIA and 106 with IS. The median time of follow-up was 30 months ranged 1\u201336 months. Ninety patients were assigned randomly to the low dose group and 91 patients to the conventional group. The rate of primary, secondary and composite efficacy were not significantly different between the low dose and conventional group (<jats:italic>P<\/jats:italic> &amp;gt; 0.05). The rate of composite safety outcome was 7.8% (7\/90) in the low dose group, which was lower than 17.6% (16\/91) in the conventional group (\u03c7<jats:sup>2<\/jats:sup> = 3.921, <jats:italic>P<\/jats:italic> = 0.048). At the time of last follow-up, 17 (9.4%) of 181 patients developed GI injuries, which occurred in four (4.4%) of 90 patients in the low dose group and in 13 (14.3%) of 91 patients in the conventional group (\u03c7<jats:sup>2<\/jats:sup> = 4.058, <jats:italic>P<\/jats:italic> = 0.044). The primary efficacy outcome occurred in six (18.2%) of 33 patients with severe sICAS and in 22 (38.6%) of 57 patients with moderate sICAS (\u03c7<jats:sup>2<\/jats:sup> = 4.064, <jats:italic>P<\/jats:italic> = 0.044) in the low dose group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this study, the safety of low dose aspirin combined with clopidogrel proved to be equally efficient and significantly safer than those of conventional dose within 24 months in elderly patients with sICAS. However, the small size of this study limits the validity of the results. Further larger longitudinal and randomized controlled trials are necessary to evaluate the role of low dose DAPT in the patients with sICAS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1060733","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T04:53:59Z","timestamp":1677732839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of low dose aspirin plus clopidogrel in the treatment of elderly patients with symptomatic intracranial artery stenosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Hai-xia","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-li","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1474-4422(18)30500-3","article-title":"Stroke in China: advances and challenges in epidemiology, prevention, and management","volume":"18","author":"Wu","year":"2019","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jnnp-2019-321564","article-title":"Is the future of symptomatic intracranial atherosclerotic stenosis management promising?","volume":"91","author":"Liu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1001\/jamaneurol.2015.4315","article-title":"Factors associated with recurrent ischemic stroke in the medical group of the SAMMPRIS trial","volume":"73","author":"Waters","year":"2016","journal-title":"JAMA Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5853\/jos.2017.01830","article-title":"Medical treatment of intracranial atherosclerosis: an update","volume":"19","author":"Kim","year":"2017","journal-title":"J Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9975583","DOI":"10.1155\/2021\/9975583","article-title":"Virtual reality-assisted percutaneous transluminal angioplasty for interventional treatment of lower-extremity arteriosclerosis obliterans","volume":"2021","author":"Zhou","year":"2021","journal-title":"J Healthc Eng."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","article-title":"Low-dose paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European randomized clinical trial (randomized trial of a novel paclitaxel-coated percutaneous angioplasty balloon)","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"17220","DOI":"10.1038\/s41598-020-74227-1","article-title":"Systematic evaluation of particle loss during handling in the percutaneous transluminal angioplasty for eight different drug-coated balloons","volume":"10","author":"Heinrich","year":"2020","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.avsg.2022.08.004","article-title":"Midterm outcomes of endovascular therapy for TASC II D femoropopliteal lesions with critical limb ischemia: a retrospective analysis","volume":"88","author":"Liu","year":"2023","journal-title":"Ann Vasc Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000358120","article-title":"Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists","volume":"37","author":"Turan","year":"2014","journal-title":"Cerebrovasc Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jama.2022.18918","article-title":"Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial","volume":"328","author":"Gao","year":"2022","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jvs.2019.02.071","article-title":"Evaluation of regional variations in length of stay after elective, uncomplicated carotid endarterectomy in North America","volume":"71","author":"Ross","year":"2020","journal-title":"J Vasc Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","article-title":"Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: report of the AAN guideline subcommittee","volume":"98","author":"Turan","year":"2022","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","article-title":"Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial","volume":"18","author":"Toyoda","year":"2019","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic","year":"2002","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1212\/WNL.0000000000001972","article-title":"Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of chance","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12883-017-0924-0","article-title":"Prevalence and risk factors of intracranial and extracranial artery stenosis in asymptomatic rural residents of 13 villages in China","volume":"17","author":"Jin","year":"2017","journal-title":"BMC Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/jnnp.2010.208330","article-title":"Symptomatic internal carotid artery occlusion: a long-term follow-up study","volume":"82","author":"Persoon","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2018.8194","article-title":"Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy","volume":"319","author":"Selak","year":"2018","journal-title":"JAMA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis."},{"key":"B23","first-page":"624","article-title":"Polypharmacy in elderly: a cautious trail to tread","volume":"63","author":"Sabzwari","year":"2013","journal-title":"J Pak Med Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1177\/000331970005101001","article-title":"Stroke: epidemiology, clinical picture, and risk factors\u2013part I of III","volume":"51","author":"Tegos","year":"2000","journal-title":"Angiology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/01.wnl.0000238506.76873.2f","article-title":"Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID","volume":"67","author":"Kasner","year":"2006","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","article-title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","volume":"16","author":"Amarenco","year":"2017","journal-title":"Lancet Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/CIRCULATIONAHA.105.578229","article-title":"Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis","volume":"113","author":"Kasner","year":"2006","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/cns.12400","article-title":"High blood pressure increases the risk of poor outcome at discharge and 12-month follow-up in patients with symptomatic intracranial large artery stenosis and occlusions: subgroup analysis of the CICAS study","volume":"21","author":"Yu","year":"2015","journal-title":"CNS Neurosci Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","article-title":"Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1060733\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T04:54:02Z","timestamp":1677732842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1060733\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":30,"alternative-id":["10.3389\/fneur.2023.1060733"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1060733","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"article-number":"1060733"}}